NextCell Pharma AB — Investor Relations & Filings
NextCell Pharma AB is a biopharmaceutical company developing advanced cell therapies for autoimmune diseases. Its lead drug candidate, ProTrans, is a novel stromal cell therapy in Phase II clinical trials for the treatment of type 1 diabetes. ProTrans is based on a patented technology platform for selecting and manufacturing potent cell products. In addition to its therapeutic development, NextCell operates Cellaviva, a private stem cell bank that provides services for the collection and storage of umbilical cord blood and tissue stem cells for future medical use. The company leverages its expertise in advanced cell handling, processing, and logistics for its clinical projects and collaborative services.
Recent filings
No filings indexed yet
We are still gathering filings for NextCell Pharma AB. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
DiaMedica Therapeutics Inc.
Clinical-stage biopharma developing therapies for ischemic …
|
DMAC | US | Manufacturing |
|
Diamyd Medical AB (publ)
A clinical-stage company developing precision therapies for…
|
DMYD | SE | Manufacturing |
|
Diasorin
A global leader in In Vitro Diagnostics for immunodiagnosti…
|
DIA | IT | Manufacturing |
|
Dicot Pharma AB
Develops a potency agent for erectile dysfunction and prema…
|
DICOTBT | SE | Manufacturing |
|
Digicann Ventures Inc.
Manufacturer and distributor of medical cannabis products a…
|
DCNN | CA | Manufacturing |
|
Disc Medicine, Inc.
Clinical-stage biopharma developing therapies for serious h…
|
IRON | US | Manufacturing |
|
Discover Wellness Solutions Inc
Licensed producer and processor of cannabis products focuse…
|
WLNS | CA | Manufacturing |
|
Dishman Carbogen Amcis Limited
Global CDMO providing integrated API development and manufa…
|
DCAL | IN | Manufacturing |
|
Divi's Laboratories Ltd.
Manufacturer of APIs and intermediates specializing in CRAM…
|
DIVISLAB | IN | Manufacturing |
|
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
Biopharmaceutical company developing innovative cancer and …
|
688192 | CN | Manufacturing |
NextCell Pharma AB via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/8504/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=8504 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=8504 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=8504 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 8504}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NextCell Pharma AB (id: 8504)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.